MC2 THERAPEUTICS LIMITED
Get an alert when MC2 THERAPEUTICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-02-15 (in 9mo)
Last made up 2026-02-01
Watchouts
None on the register
Name history
Renamed 1 time since incorporation
- MC2 THERAPEUTICS LIMITED 2019-02-05 → present
- DRUG DELIVERY SOLUTIONS LIMITED 2005-02-01 → 2019-02-05
Accounts
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the directors' assessment they consider that there is sufficient working capital for the company to continue for a period of at least 12 months from the date of signing of the financial statements and therefore it is appropriate to prepare the financial statements on a going concern basis.”
Group structure
- MC2 THERAPEUTICS LIMITED · parent
- Disperse Pharma Limited 100%
- MC2 Therapeutics PTY LTD 100%
Significant events
- “Subsequent to year-end 2024, MC2 Therapeutics has entered into agreements with partners in Australia and Canada to further strengthening the global roll-out of Wynzora® Cream.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HILTON, Tim | Secretary | 2024-12-19 | — | — |
| AHLGREEN, Trine | Director | 2026-01-27 | Aug 1975 | Danish |
| HARRISON, Christopher Neil | Director | 2025-12-18 | Nov 1971 | British |
| MIKKELSEN, Tomas Dahl | Director | 2022-12-22 | May 1980 | Danish |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| TWYDELL, Richard William | Secretary | 2005-02-01 | 2024-12-19 |
| BUDOLFSEN, Elsebeth | Director | 2005-11-04 | 2009-11-01 |
| CLAUSEN, Anette Merete Nohr | Director | 2005-07-12 | 2018-11-13 |
| CLAUSEN, Mads Jorgen Nohr | Director | 2008-06-25 | 2026-01-31 |
| CRUTCHLEY, Nigel, Dr | Director | 2018-11-13 | 2023-03-13 |
| LANGE, Jesper Jorn | Director | 2008-06-25 | 2022-12-22 |
| LENON, Stephen John, Dr | Director | 2005-02-01 | 2022-12-29 |
| PRAESTEGAARD, Morten | Director | 2018-11-13 | 2022-12-22 |
| PRIMROSE, Kenneth Mark | Director | 2005-11-04 | 2007-03-01 |
| SINDET PEDERSEN, Steen, Professor | Director | 2005-07-12 | 2012-12-31 |
| TWYDELL, Richard William | Director | 2005-02-01 | 2018-11-13 |
| WHEELER, Derek Alfred | Director | 2005-07-12 | 2018-11-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mc2 Therapeutics A/S | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 120 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-11 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-02-06 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-27 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-18 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-24 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-10-06 | AA | accounts | Accounts with accounts type full | |
| 2025-02-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-07 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-01-07 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-09-28 | AA | accounts | Accounts with accounts type small | |
| 2024-02-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-12-21 | SH01 | capital | Capital allotment shares | |
| 2023-09-26 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-08-02 | AA | accounts | Accounts with accounts type small | |
| 2023-03-13 | TM01 | officers | Termination director company with name termination date | |
| 2023-02-03 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-12-29 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-23 | SH01 | capital | Capital allotment shares | |
| 2022-12-22 | CH01 | officers | Change person director company with change date | |
| 2022-12-22 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one